These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Kohashi K; Oda Y Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176 [TBL] [Abstract][Full Text] [Related]
23. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189 [TBL] [Abstract][Full Text] [Related]
24. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280 [TBL] [Abstract][Full Text] [Related]
25. Atypical Teratoid/Rhabdoid Sellar Tumor in an Adult with a Familial History of a Germline SMARCB1 Mutation: Case Report and Review of the Literature. Voisin MR; Ovenden C; Tsang DS; Gupta AA; Huang A; Gao AF; Diamandis P; Almeida JP; Gentili F World Neurosurg; 2019 Jul; 127():336-345. PubMed ID: 31004861 [TBL] [Abstract][Full Text] [Related]
26. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4). Bookhout C; Bouldin TW; Ellison DW Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065 [TBL] [Abstract][Full Text] [Related]
27. SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors. Kim SS; Moghe M; Rait A; Donaldson K; Harford JB; Chang EH Int J Nanomedicine; 2024; 19():5973-5993. PubMed ID: 38895149 [TBL] [Abstract][Full Text] [Related]
28. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491 [TBL] [Abstract][Full Text] [Related]
30. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults. Thomas C; Wefers A; Bens S; Nemes K; Agaimy A; Oyen F; Vogelgesang S; Rodriguez FJ; Brett FM; McLendon R; Bodi I; Burel-Vandenbos F; Keyvani K; Tippelt S; Poulsen FR; Lipp ES; Giannini C; Reifenberger G; Kuchelmeister K; Pietsch T; Kordes U; Siebert R; Frühwald MC; Johann PD; Sill M; Kool M; von Deimling A; Paulus W; Hasselblatt M Acta Neuropathol; 2020 Feb; 139(2):277-286. PubMed ID: 31732806 [TBL] [Abstract][Full Text] [Related]
31. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1]. Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778 [TBL] [Abstract][Full Text] [Related]
32. Reclassification of rhabdoid tumor and pediatric undifferentiated/unclassified sarcoma with complete loss of SMARCB1/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features. Kohashi K; Tanaka Y; Kishimoto H; Yamamoto H; Yamada Y; Taguchi T; Iwamoto Y; Oda Y Mod Pathol; 2016 Oct; 29(10):1232-42. PubMed ID: 27338635 [TBL] [Abstract][Full Text] [Related]
33. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description. Barresi V; Lionti S; Raso A; Esposito F; Cannavò S; Angileri FF Neuropathology; 2018 Jun; 38(3):260-267. PubMed ID: 29110337 [TBL] [Abstract][Full Text] [Related]
34. Atypical teratoid/rhabdoid tumor of the central nervous system in an 18-year-old patient. Samaras V; Stamatelli A; Samaras E; Stergiou I; Konstantopoulou P; Varsos V; Judkins AR; Biegel JA; Barbatis C Clin Neuropathol; 2009; 28(1):1-10. PubMed ID: 19216214 [TBL] [Abstract][Full Text] [Related]
35. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300 [TBL] [Abstract][Full Text] [Related]
36. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974 [TBL] [Abstract][Full Text] [Related]
37. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370 [TBL] [Abstract][Full Text] [Related]
38. Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry With Analysis of Cyclin D1 Overexpression and Sali AP; Epari S; Nagaraj TS; Sahay A; Chinnaswamy G; Shetty P; Moiyadi A; Gupta T Int J Surg Pathol; 2021 Apr; 29(2):155-164. PubMed ID: 32703045 [No Abstract] [Full Text] [Related]